Rubicon Research Limited Highlights Strong Focus on Sustainability and Operational Excellence in Pharmaceutical Industry

Rubicon Research Limited Highlights Strong Focus on Sustainability and Operational Excellence in Pharmaceutical Industry​

Rubicon Research Limited, a key player in pharmaceutical formulations, has highlighted its commitment to ethical business conduct and environmental stewardship through its annual reporting period covering FY 2025-26. The company maintains a robust focus on quality control and sustainability across its operations, supporting growth driven by international markets.

The company's core business activity is focused entirely on pharmaceutical formulation, specializing in developing, manufacturing, and marketing branded specialty and generic products. Rubicon Research operates both nationally and internationally, with 3 states representing national presence and the company serving 8 countries abroad. Exports account for a significant majority of turnover at 98.44%.

Operational Scale and Human Capital Development​

Rubicon Research employs a dedicated workforce totaling 1,303 employees and workers across its operations. The company actively promotes inclusive leadership by ensuring strong representation in senior roles: the Board of Directors features 25% women members, while Key Management Personnel (KMP) include 50% female representation.

Commitment to labor welfare is underscored by consistent operational safety results. Both for FY 2025-26 and FY 2024-25, the company reported a Lost Time Injury Frequency Rate (LTIFR) of zero for both employees and workers. The company ensures compliance with related regulations, with all manufacturing locations being assessed regarding health and safety practices.

The organization is deeply committed to human capital development, investing in employee training and awareness programs. For instance, 94% of non-director/KMP employees participated in awareness programs covering topics such as Code of Conduct and anti-corruption measures. Furthermore, the company has invested substantially in operational integrity, with a high percentage of R&D and capital expenditure (Capex) dedicated to technological advancements and environmental improvement.

Environmental Stewardship and Resource Management​

Environmental stewardship is a central pillar of Rubicon Research’s strategy. The company utilizes Zero Liquid Discharge (ZLD) mechanisms at several manufacturing facilities, ensuring that process and domestic wastewater is treated through comprehensive primary, secondary, and tertiary processes before the water is reused for gardening or cooling tower make-up purposes. No liquid effluent is discharged into surface water from any location.

The firm maintains rigorous control over waste generation. All hazardous waste streams are strictly managed in accordance with relevant regulations, being exclusively sent to authorized Treatment, Storage, and Disposal (TSDF) facilities. The company also makes significant strides in reducing its environmental footprint through initiatives such as replacing conventional lighting with LEDs and installing Variable Frequency Drives (VFDs).


The company's commitment extends to sustainable resource usage in the supply chain, with a notable shift towards improving resource recovery; hazardous waste from FY 2025-26 was sent for co-processing rather than incineration or landfill disposal.

Stakeholder Engagement and Governance​

Rubicon Research maintains transparent engagement across all stakeholder groups. The company’s governance framework is designed to integrate ESG considerations into strategic priorities, with the Board of Directors and its Audit and Risk Management Committees providing active oversight of sustainability-related matters.

The firm's business ethics are reinforced through a Code of Conduct and Whistle Blower Policy, ensuring that employees and partners can report concerns without fear of retaliation. The company also manages consumer relations meticulously, operating a Pharmacovigilance system to handle adverse event reporting and maintaining product safety standards in line with regulatory requirements.

A dedicated focus on human rights has guided the company’s processes. All business agreements incorporate human rights principles, ensuring that all stakeholders adhere to ethical and fair employment practices. The management is committed to continuous improvement across all operational aspects, striving to uphold global best practices in manufacturing while contributing meaningfully to social development through its community engagement programs.

RUBICON Stock Price Movement​

Shares of Rubicon Research Limited slipped by 0.07% on Monday, closing at ₹1500.8 after trading saw movement throughout the session. The security settled amidst intraday fluctuations and completed trading with a volume of 93,519 shares.